Apr. 17 at 3:01 AM
$UNCY I expect sideways chop for another 4 weeks possibly 6 and a grind towards
$8-
$10 pre pdufa. I'm not sure what happens post pdufa. There is some funding concerns to launch the drug if they do it solo, but the big question for me is do they go about it solo, do they partner, do they get bought out?
OLC performs better than other options on the market. If TDAPA is approved coupled with patent protection to 2035, I'm betting this is a buy out or at least a strong partnership target pretty quickly. If either of those things happen, I don't think dilution is as much a concern.
I'm curious what others are targeting for approval price? I'd be happy if it hit the
$12-
$15 range but that might be too much dreaming. Here's my bet if pre pdufa price is 8 or less id bet
$10 on approval. If it's
$10 on pdufa day, I'm betting
$12-
$15
